Women’s involvement in clinical trials: historical perspective and future implications

The importance of considering the differences between the male and female sex in clinical decision-making is crucial. However, it has been acknowledged in recent decades that clinical trials have not always adequately enrolled women or analyzed sex-specific differences in the data. As these deficiencies have hindered the progress of understanding women’s response to medications, agencies in the United States have worked towards the inclusion of women in clinical trials and appropriate analysis of sex-specific data from clinical trials. This review outlines the history and progress of women’s inclusion in clinical trials for prescription drugs and presents considerations for researchers, clinicians, and academicians on this issue.

[1]  Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice. , 1993, Federal register.

[2]  R. Woosley.  From bench to bedside: role of gender-based therapeutics in the clinical care of women. , 1998, Journal of women's health.

[3]  Investigational new drug applications and new drug applications--FDA. Final rule. , 1998, Federal register.

[4]  H Derendorf,et al.  Gender differences in pharmacokinetics and pharmacodynamics. , 1999, International journal of clinical pharmacology and therapeutics.

[5]  C. Meinert,et al.  Gender representation in trials. , 2000, Controlled clinical trials.

[6]  Participation of women in clinical trials of drug therapies: a context for the controversies. , 2001 .

[7]  V. Muller.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[8]  Theresa M. Wizemann,et al.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[9]  M. Prout,et al.  Participation of women in clinical trials of drug therapies: a context for the controversies. , 2001, Medscape women's health.

[10]  B. Mikulski,et al.  Drug Safety : Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women , 2001 .

[11]  L. Doyal.  Sex, gender, and health: the need for a new approach , 2001, BMJ : British Medical Journal.

[12]  M. Miller.  Gender-Based Differences in the Toxicity of Pharmaceuticals—The Food and Drug Administration's Perspective , 2001, International journal of toxicology.

[13]  D. Bowen,et al.  Promoting adherence and retention to clinical trials in special populations: a women's health initiative workshop. , 2001, Controlled clinical trials.

[14]  Londa Schiebinger,et al.  Women's health and clinical trials. , 2003, The Journal of clinical investigation.

[15]  V. Pinn,et al.  Sex and gender factors in medical studies: implications for health and clinical practice. , 2003, JAMA.

[16]  P. Thuermann.  Gender-differences in pharmacokinetics and pharmacodynamics , 2006 .

[17]  J. Coverdale,et al.  Preventive ethics for including women of childbearing potential in clinical trials. , 2006, American journal of obstetrics and gynecology.

[18]  S. Geller,et al.  Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. , 2006, Journal of women's health.

[19]  Wendy R. Sanhai,et al.  Advancing women's health via FDA Critical Path Initiative. , 2007, Drug discovery today. Technologies.

[20]  J. Berlin,et al.  Inclusion of women in clinical trials , 2009, BMC medicine.

[21]  S. Geller,et al.  Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress? , 2011, Journal of women's health.

[22]  D. Throckmorton,et al.  Adverse effects in women: implications for drug development and regulatory policies , 2011, Expert review of clinical pharmacology.

[23]  Julie Taylor,et al.  Women's Health Research: Progress, Pitfalls, and Promise , 2011 .

[24]  Lei Zhang,et al.  Participation of women and sex analyses in late-phase clinical trials of new molecular entity drugs and biologics approved by the FDA in 2007-2009. , 2013, Journal of women's health.